Understanding the impact of new TB vaccines using mathematical models
Estimating the Epidemiologic Impact of TB Vaccines using Mathematical Models
This study is looking at how new and existing vaccines for tuberculosis (TB) could help improve health in low- and middle-income countries, especially for those at higher risk, by figuring out the best ways to use these vaccines to lower TB cases and deaths.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Emory University NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project ID | NIH-10892218 on NIH RePORTER |
What this research studies
This research investigates the potential effects of new and repurposed tuberculosis (TB) vaccines on public health, particularly in low- and middle-income countries. By utilizing mathematical models and data from various countries, the study aims to estimate how these vaccines could reduce TB cases and deaths. The research focuses on high-risk groups and evaluates different vaccination strategies to maximize the impact of these vaccines. Patients may benefit from insights that could lead to improved vaccination programs and better health outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals living in regions with high TB prevalence, particularly those at higher risk of infection.
Not a fit: Patients who are not at risk for TB or live in areas with low TB incidence may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective TB vaccination strategies, significantly reducing TB infections and deaths.
How similar studies have performed: Previous research has shown promise with similar vaccine approaches, indicating potential for significant advancements in TB prevention.
Where this research is happening
Atlanta, United States
- Emory University — Atlanta, United States (Active)
Researchers
- Principal investigator: Nelson, Kristin Nicole Bratton — Emory University
- Study coordinator: Nelson, Kristin Nicole Bratton
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.